Evidence map›Paper›PMID 32348546›Full record

ArticleClinical and experimental immunology2020

High-throughput analysis of T cell-monocyte interaction in human tuberculosis.

M Habtamu, G Abrahamsen, A Aseffa, E Andargie, S Ayalew, M Abebe, A Spurkland

Open access · hybridAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. CD4International journal of molecular sciences · 2024
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

M HabtamuDepartment of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Olso, Norway.ORCID 0000-0002-1627-698X
G AbrahamsenDepartment of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Olso, Norway.
A AseffaArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
E AndargieArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
S AyalewArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
M AbebeArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
A SpurklandDepartment of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Olso, Norway.
Armauer Hansen Research Institute · ETUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The lack of efficient tools for identifying immunological correlates of tuberculosis (TB) protection or risk of disease progression impedes the development of improved control strategies. To more clearly understand the host response in TB, we recently established an imaging flow cytometer-based in-vitro assay, which assesses multiple aspects of T cell-monocyte interaction. Here, we extended our previous work and characterized communication between T cells and monocytes using clinical samples from individuals with different TB infection status and healthy controls from a TB endemic setting. To identify T cell-monocyte conjugates, peripheral blood mononuclear cells (PBMC) were stimulated with ds-Red-expressing Mycobacterium bovis bacille Calmette-Guérin or 6-kDa early secreted antigenic target (ESAT 6) peptides for 6 h, and analyzed by imaging flow cytometer (IFC). We then enumerated T cell-monocyte conjugates using polarization of T cell receptor (TCR) and F-actin as markers for synapse formation, and nuclear factor kappa B (NF-κB) nuclear translocation in the T cells. We observed a reduced frequency of T cell-monocyte conjugates in cells from patients with active pulmonary tuberculosis (pTB) compared to latent TB-infected (LTBI) and healthy controls. When we monitored NF-κB nuclear translocation in T cells interacting with monocytes, the proportion of responding cells was significantly higher in active pTB compared with LTBI and controls. Overall, these data underscore the need to consider multiple immunological parameters against TB, where IFC could be a valuable tool.

Indexed as

ActinsAdolescentAdultAntigens, BacterialBacterial ProteinsCell CommunicationFemaleHigh-Throughput Screening AssaysHumansMaleMiddle AgedMonocytesMycobacterium bovisMycobacterium tuberculosisNF-kappa BReceptors, Antigen, T-CellActinsAntigens, BacterialBacterial ProteinsESAT-6 protein, Mycobacterium tuberculosisNF-kappa BReceptors, Antigen, T-Cellcell activationmonocyteT cell

Identifiers

PMID32348546
PMCPMC7366737
OpenAlexW3018445963

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.